Beta-sitosterol plant extract in treatment of benign prostatic hyperplasia

Last reviewed 01/2018

Authors of a systematic review concluded (1):

  • evidence suggests non-glucosidic Beta-sitosterols improve urinary symptoms and flow measures. Their long term effectiveness, safety and ability to prevent benign prostatic hyperplasia (BPH) complications are not known

A Clinical Evidence review categorised beta-sitosterol plant extract as a treatment modality likely to be beneficial in BPH

Reference:

  1. Wilt T et al. Beta-sitosterols for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2000;(2):CD001043
  2. Clinical Evidence (April 2006). Benign Prostatic Hyperplasia.

Related pages:

benign prostatic hyperplasia